- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
FOXA1 is a determinant of drug resistance in breast cancer cells ; day:8 ; month:1 ; year:2021 ; pages:1-10
Breast cancer research and treatment ; (8.1.2021), 1-10
- Urheber
-
Kumar, Uttom
Ardasheva, Anastasia
Mahmud, Zimam
Coombes, R. Charles
Yagüe, Ernesto
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-020-06068-5
- URN
-
urn:nbn:de:101:1-2021020823413961425528
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kumar, Uttom
- Ardasheva, Anastasia
- Mahmud, Zimam
- Coombes, R. Charles
- Yagüe, Ernesto
- SpringerLink (Online service)
Ähnliche Objekte (12)
Androgen receptor is a determinant of melanoma targeted drug resistance
Exosomes and breast cancer drug resistance
Unravelling Drug Resistance Mechanisms in Breast Cancer
LIN7A is a major determinant of cell-polarity defects in breast carcinomas
MicroRNA-mediated drug resistance in breast cancer
Environmental chemicals, breast cancer progression and drug resistance
Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab
Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers
CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
Androgen receptor is a determinant of melanoma targeted drug resistance
Exosomes and breast cancer drug resistance
Unravelling Drug Resistance Mechanisms in Breast Cancer
LIN7A is a major determinant of cell-polarity defects in breast carcinomas
MicroRNA-mediated drug resistance in breast cancer
Environmental chemicals, breast cancer progression and drug resistance
Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab
Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers
CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
Androgen receptor is a determinant of melanoma targeted drug resistance
Exosomes and breast cancer drug resistance
Unravelling Drug Resistance Mechanisms in Breast Cancer
LIN7A is a major determinant of cell-polarity defects in breast carcinomas
MicroRNA-mediated drug resistance in breast cancer
Environmental chemicals, breast cancer progression and drug resistance
Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab
Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers
CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer